MINNEAPOLIS, April 27, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope⢠technology with release of new DNAscope Assays. The RNAscope technology is an advanced
in situ hybridization (ISH) assay that enables visualization of single-molecule gene expression with single-cell resolution directly in intact cells and tissues.
Bio-Techne s new chromogenic DNA
in situ hybridization (ISH) technology, DNAscope, employs the proven double-Z probe design and signal amplification system of RNAscope, enabling rapid and flexible probe development for any DNA target, enabling visualization of targets in formalin-fixed paraffin-embedded (FFPE) tissues. DNAscope delivers benefits over current commercial FISH techniques that fall short on morphological detail due to the use of fluorescent nuclear staining and rely on high-resolution microscopes to visualize gene rearrangement and copy n
Kim-kelderman
David-clair
Prnewswire-bio-techne-corporation
Research-use
Corporate-development
Bio-techne-corporation
Techne-corporation
Advanced-cell-diagnostics
Bacterial-artificial-chromosome
Senior-director
Investor-relations
கிம்-கேள்தேர்மன்